Primary Causes & Pathophysiology
Nephrolithiasis develops when the concentration of stone-forming solutes (e.g., calcium, oxalate, uric acid) exceeds their solubility in the urine, a state known as supersaturation. This leads to nucleation, where crystals form and aggregate into a solid mass. Inhibitors of crystallisation, such as citrate, magnesium, and pyrophosphate, normally prevent this process; their depletion promotes stone growth. Stones may remain asymptomatic within the renal calyces or cause severe pain (renal colic) and mucosal injury if they migrate and obstruct the urinary tract, leading to increased intraluminal pressure, capsular stretch, and ureteral spasm. Obstruction can also precipitate urinary stasis and secondary bacterial infection.
Excessive renal calcium excretion despite normal serum calcium levels, leading to supersaturation of calcium oxalate or calcium phosphate.
Increased intestinal absorption of oxalate (e.g., in fat malabsorption or high-oxalate diets) results in high urinary oxalate, strongly promoting calcium oxalate crystallisation.
Elevated urinary uric acid lowers the pH and provides a nidus for heterogeneous nucleation of calcium oxalate or forms pure uric acid stones in acidic urine.
Reduced urinary citrate removes a key inhibitor of calcium crystallisation, allowing calcium salts to precipitate more readily.
Excess parathyroid hormone increases bone resorption and renal calcium filtration, causing hypercalcaemia and hypercalciuria.
Bacteria such as Proteus mirabilis secrete urease, which hydrolyses urea into ammonia, alkalinising the urine and precipitating magnesium ammonium phosphate (struvite) stones.